Unglycosylation at Asn-633 Made Extracellular Domain of E-cadherin Folded Incorrectly and Arrested in Endoplasmic Reticulum, then Sequentially Degraded by ERAD

Feng Zhou,Jianmin Su,Le Fu,Yong Yang,Lineng Zhang,Liying Wang,Hongbo Zhao,Diancai Zhang,Zengxia Li,Xiliang Zha
DOI: https://doi.org/10.1007/s10719-008-9133-9
2008-01-01
Glycoconjugate Journal
Abstract:The human E-cadherin is a single transmembrane domain protein involved in Ca2+-dependent cell–cell adhesion. In a previous study, we demonstrated that all of four potential N-glycosylation sites in E-cadherin are occupied by N-glycans in human breast carcinoma cells in vivo and the elimination of N-glycan at Asn-633 dramatically affected E-cadherin expression and made it degraded. In this study we investigated the molecular mechanism of E-cadherin, which lacks N-glycosylation at Asn-633 (M4), degradation and the role of the N-glycan at Asn-633 in E-cadherin folding. We treated cells stably expressed M4 E-cadherin with MG123, DMM, respectively. Either MG132 or DMM could efficiently block degradation of M4 E-cadherin. M4 E-cadherin was recognized as the substrate of ERAD and was retro-translocated from ER lumen to cytoplasm by p97. It was observed that the ration of M4 E-cadherin binding to calnexin was significantly increased compared with that of other variants, suggesting that it was a misfolded protein, though cytoplasmic domain of M4 E-cadherin could associate with β-catenin. Furthermore, we found that N-glycans of M4 E-cadherin were modified in immature high mannose type, suggesting that it could not depart to Golgi apparatus. In conclusion, this study revealed that N-glycosylation at Asn-633 is essential for E-cadherin expression, folding and trafficking.
What problem does this paper attempt to address?